COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC:

Get the latest research information from NIH: Menu
Trial record 2 of 71 for:    Recruiting, Not yet recruiting Studies | Immune Thrombocytopenia

Eltrombopag vs Standard Front Line Management for Newly Diagnosed Immune Thrombocytopenia (ITP) in Children

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. Identifier: NCT03939637
Recruitment Status : Recruiting
First Posted : May 7, 2019
Last Update Posted : February 21, 2020
Boston Children’s Hospital
University of California, San Francisco
Information provided by (Responsible Party):
Jenny Despotovic, Baylor College of Medicine

No Study Results Posted on for this Study
Recruitment Status : Recruiting
Estimated Primary Completion Date : May 1, 2022
Estimated Study Completion Date : November 30, 2024